Read + Share
Amedeo Smart
Independent Medical Education
van den Hoogen P, de Jager SCA, Mol EA, Schoneveld AS, et al. Potential of mesenchymal- and cardiac progenitor cells for therapeutic targeting of B-cells and antibody responses in end-stage heart failure. PLoS One 2019;14:e0227283.PMID: 31891633
Email
LinkedIn
Facebook
Twitter
Privacy Policy